Cleared Traditional

K183120 - EmboCube Embolization Gelatin

K183120 is an FDA 510(k) clearance for EmboCube Embolization Gelatin, manufactured by Biosphere Medical, S.A.. The device is a Class 2 Cardiovascular device with product code KRD cleared through the Traditional 510(k) pathway after a 270-day FDA review.

K183120 · Biosphere Medical, S.A. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
270d
Days
Class 2
Risk

K183120 is an FDA 510(k) clearance for the EmboCube Embolization Gelatin. Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Biosphere Medical, S.A. (Roissy-En-France, FR). The FDA issued a Cleared decision on August 6, 2019 after a review of 270 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosphere Medical, S.A. devices

FDA 510(k) Submission Details - K183120

510(k) Number K183120 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 2018
Decision Date August 06, 2019
Days to Decision 270 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
145d slower than avg
Panel avg: 125d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRD Device Classification - Class 2, Special Controls

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 97
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K183120.
The Caterpillar and Caterpillar Micro Arterial Embolization Devices
K191532 · C.R. Bard, Inc. · Feb 2020
Torpedo Gelatin Foam
K192480 · Biosphere Medical, S.A. · Nov 2019
Okami Medical LOBO Vascular Occlusion System
K192083 · Okami Medical · Oct 2019
Torpedo Gelatin Foam
K183578 · Biosphere Medical, S.A. · Jun 2019
IMPEDE-FX Embolization Plug
K182390 · Shape Memory Medical · May 2019
Dr. Amplatz Micro Plug
K182944 · Ka Medical, LLC · Apr 2019